Targets for Cancer IO: A Deep Dive Series

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a second highly anticipated series of nine live webinars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.

Each of the nine webinars will feature leaders in the immuno-oncology field who are experts in a given subject area to provide an overview of the current scientific knowledge about a therapy. An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.

ORGANIZER PREVIEW

Find out what differentiates this series from many other webinars with one of our incredible co-organizers, Daniel Chen, MD, PhD, and founder of Engenuity Life Sciences.

Program Organizers

Dan Chen, MD, PhD - Engenuity Life Sciences
Kristen Hege, MD - Bristol Myers Squibb
Ira Mellman, PhD - Genentech
Mario Sznol, MD - Yale School of Medicine
Cassian Yee, MD - MD Anderson Cancer Center

Registration is now available for the second series of Deep Dive live webinars. Please note at the time of your registration, if you purchase four of the nine webinars, you are able to register for the remainder at no additional cost. If you have any questions, please reach out to education@sitcancer.org.
 

Register Here

Below is a list of the seminars available for registration.

Live Webinar 1 – LAG-3 Biology and current clinical Results

• Date of Live Event: Monday, June 13, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Drew M. Pardoll, MD, PhD – Johns Hopkins University
  • Dario A.A. Vignali, PhD – University of Pittsburgh
• Faculty:
  • Tullia C. Bruno, PhD – University of Pittsburgh
  • Evan J. Lipson, MD – Johns Hopkins University
  • Dario A.A. Vignali, PhD – University of Pittsburgh

Live Webinar 2 – Recombinant Interleukin-18 Immunotherapy

• Date of Live Event: Monday, July 18, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Michael T. Lotze, MD, FACS – Nurix Therapeutics
  • Aaron M. Ring, MD, PhD – Yale University School of Medicine
• Faculty:
  • Scott W. Canna, MD - University of Pennsylvania, The Children's Hospital of Philadelphia
    
  • Simone A. Minnie, PhD - Fred Hutchinson Cancer Research Center

Live Webinar 3 –TIL Therapies

• Date of Live Event: Thursday, July 28, 2022 – 11 a.m.–1 p.m. CDT
• Moderators:
  • Brian R. Gastman, MD – Cleveland Clinic Cancer Center
    
  • Stephanie L. Goff, MD, FACS – National Cancer Institute Surgery Branch
• Faculty:
  • Amod A. Sarnaik, MD - H.Lee Moffitt Cancer Center and Research Institute

Live Webinar 4 – Targeted systemic delivery of innate immune activators

• Date of Live Event: Friday, Aug. 26, 2022 – 10 a.m.–12 p.m. CDT
• Moderators:
  
  • Timothy Lowinger, PhD – Mersana Therapeutics
  • Valerie Odegard, PhD – Silverback Therapeutics
• Faculty:
  
  • TBD
    

Live Webinar 5 – Scientific basis of B-cell modulation for anti-tumor immunity and reduction of ICI toxicity

• Date of Live Event: Thursday, Sept.15, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Tullia C. Bruno, PhD – University of Pittsburgh
  • Daniel Hollern, PhD – The Salk Institute for Biological Studies
• Faculty:
  • Karen WIllard-Gallo, PhD - Institut Jules Bordet
    
  • Yuliya Pylayeva-Gupta, PhD - UNC at Chapel Hill
  • Brad Nelson, PhD - BC Cancer-Deeley Research Center

Live Webinar 6 – iPSC derived cell therapies 

• Date of Live Event: Monday, Sept. 26, 2022 – 10 a.m.–12 p.m. CDT
• Moderators:
  • Kalle Malmberg, MD, PhD – Oslo University Hospital
  • Jeffrey S. Miller, MD – University of Minnesota
• Faculty:
  • Ran Jing, PhD - Boston Children's Hospital
    
  • Sjouke van der Stegen, PhD - Memorial Sloan Kettering, The Michael Sadelain Lab

Live Webinar 7 – Enhanced CTLA-4  blockade

• Date of Live Event: Wednesday, Oct. 5, 2022 – 1 p.m.–3 p.m. CDT
• Moderators:
  • James P. Allison, PhD, FAIO – The University of Texas MD Anderson Cancer Center
  • Alan J. Korman, PhD, FAIO – Vir Biotechnology
• Faculty:
  
  • TBD
    
    

Live Webinar 8 – TCR Based Therapeutics

• Date of Live Event: Wednesday, Dec. 7, 2022 – 2 p.m.–4 p.m. CST
• Moderators:
  
  • Harlan Robins, PhD – Adaptive Biotechnologies Corporation
  • Harpreet Singh, PhD – Immatics Biotechnologies GmbH
• Faculty:
  • TBD

Live Webinar 9 – NK cell engagers  

• Date of Live Event: Wednesday, Jan. 11, 2023 – 10 a.m.–12 p.m. CST
• Moderators:
  
  • Adelheid Cerwenka, PhD – Heidelberg University
  • Lewis L. Lanier, PhD – University of California, San Francisco
• Faculty:
  • TBD